7th SCI/RSC Symposium on GPCRs in Medicinal Chemistry

September 10-12, 2018 | Verona, Italy

We announce that we will be hosting the 7th SCI/RSC Symposium on GPCRs in Medicinal Chemistry Symposium at our site in Verona, Italy.

We are proud to be the main sponsor of this important scientific event which is organised by SCI's  Fine Chemicals Group and RSC's Biological and Medicinal Chemistry Sector.

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will once again support the seventh meeting in this series on GPCR drug discovery, combining cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

Speakers and Programme
The full programme is now available on
Keynote speakers are:
Allosteric modulators of GPCRs: theoretical and practical considerations
Arthur Christopoulos, Monash University, Australia

GPCR Consortium:  four years of progress in structural biology
Michael Hanson, GPCR Consortium, USA

Structure and mechanism of human CNS GPCRs
Daniel Rosenbaum, University of Texas Southwestern Medical Center, USA

Shedding light on G protein bias: structures of GPCRs coupled to G proteins determined by cryo-EM and X-ray crystallography
Chris Tate, MRC Laboratory of Molecular Biology, UK

This meeting will be of interest to medicinal chemists, pharmacologists, computational chemists, structural biologists and all those involved in drug discovery.

Registration is open!

You can register via the GPCRs in Medicinal Chemistry symposium site
Register by 5th June 2018 to get the early registration fees

Topics: Events, Drug Discovery, Partner Research Organization, Medicinal Chemistry, GPCRs


January 2017

9-12 | JP Morgan Healthcare Conference
San Francisco, USA

26-27 | Notocord 4th User Meeting Group
Saint Germain-en-Laye, France

February 2017

4-8 | SLAS International Conference and Exhibition
Washington DC, USA

March 2017

20-23 | DCAT Week '17
New York, USA

Most Read